How should we interpret the two transport relaxation times in the cuprates ?

We observe that the appearance of two transport relaxation times in the various transport coefficients of cuprate metals may be understood in terms of scattering processes that discriminate between currents that are even, or odd under the charge conjugation operator. We develop a transport equation that illustrates these ideas and discuss its experimental and theoretical consequences.Comment: 19 pages, RevTeX with 8 postscript figures included. To appear in ``Non Fermi Liquid Physics'', J. Phys:Cond. Matt. (1997

Sum rule for the optical Hall angle

We consider the optical Hall conductivity of a general electronic medium and prove that the optical Hall angle obeys a new sum rule. This sum rule governs the response of an electronic fluid to a Lorentz electric field and can thought of as the transverse counterpart to the f-sum rule in optical conductivity. The physical meaning of this sum rule is discussed, giving a number of examples of its application to a variety of of electronic media.Comment: Four pages. Latex file with two postscript figure

Infrared Hall effect in high Tc superconductors: Evidence for non-Fermi liquid Hall scattering

Infrared (20-120 cm-1 and 900-1100 cm-1) Faraday rotation and circular dichroism are measured in high Tc superconductors using sensitive polarization modulation techniques. Optimally doped YBCO thin films are studied at temperatures down to 15 K and magnetic fields up to 8 T. At 1000 cm-1 the Hall conductivity varies strongly with temperature in contrast to the longitudinal conductivity which is nearly independent of temperature. The Hall scattering rate has a T^2 temperature dependence but, unlike a Fermi liquid, depends only weakly on frequency. The experiment puts severe constraints on theories of transport in the normal state of high Tc superconductors.Comment: 8 pages, 3 figure

Rising tides or rising stars?: Dynamics of shared attention on twitter during media events

"Media events" generate conditions of shared attention as many users simultaneously tune in with the dual screens of broadcast and social media to view and participate. We examine how collective patterns of user behavior under conditions of shared attention are distinct from other "bursts" of activity like breaking news events. Using 290 million tweets from a panel of 193,532 politically active Twitter users, we compare features of their behavior during eight major events during the 2012 U.S. presidential election to examine how patterns of social media use change during these media events compared to "typical" time and whether these changes are attributable to shifts in the behavior of the population as a whole or shifts from particular segments such as elites. Compared to baseline time periods, our findings reveal that media events not only generate large volumes of tweets, but they are also associated with (1) substantial declines in interpersonal communication, (2) more highly concentrated attention by replying to and retweeting particular users, and (3) elite users predominantly benefiting from this attention. These findings empirically demonstrate how bursts of activity on Twitter during media events significantly alter underlying social processes of interpersonal communication and social interaction. Because the behavior of large populations within socio-technical systems can change so dramatically, our findings suggest the need for further research about how social media responses to media events can be used to support collective sensemaking, to promote informed deliberation, and to remain resilient in the face of misinformation. © 2014 Lin et al

Anomalous Transport Phenomena in Fermi Liquids with Strong Magnetic Fluctuations

In many strongly correlated electron systems, remarkable violation of the relaxation time approximation (RTA) is observed. The most famous example would be high-Tc superconductors (HTSCs), and similar anomalous transport phenomena have been observed in metals near their antiferromagnetic (AF) quantum critical point (QCP). Here, we develop a transport theory involving resistivity and Hall coefficient on the basis of the microscopic Fermi liquid theory, by considering the current vertex correction (CVC). In nearly AF Fermi liquids, the CVC accounts for the significant enhancements in the Hall coefficient, magnetoresistance, thermoelectric power, and Nernst coefficient in nearly AF metals. According to the numerical study, aspects of anomalous transport phenomena in HTSC are explained in a unified way by considering the CVC, without introducing any fitting parameters; this strongly supports the idea that HTSCs are Fermi liquids with strong AF fluctuations. In addition, the striking \omega-dependence of the AC Hall coefficient and the remarkable effects of impurities on the transport coefficients in HTSCs appear to fit naturally into the present theory. The present theory also explains very similar anomalous transport phenomena occurring in CeCoIn5 and CeRhIn5, which is a heavy-fermion system near the AF QCP, and in the organic superconductor \kappa-(BEDT-TTF).Comment: 100 pages, Rep. Prog. Phys. 71, 026501 (2008

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Background: Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a BRCA mutation or high percentage of genome-wide loss of heterozygosity. In this trial we assessed rucaparib versus placebo after response to second-line or later platinum-based chemotherapy in patients with high-grade, recurrent, platinum-sensitive ovarian carcinoma. Methods: In this randomised, double-blind, placebo-controlled, phase 3 trial, we recruited patients from 87 hospitals and cancer centres across 11 countries. Eligible patients were aged 18 years or older, had a platinum-sensitive, high-grade serous or endometrioid ovarian, primary peritoneal, or fallopian tube carcinoma, had received at least two previous platinum-based chemotherapy regimens, had achieved complete or partial response to their last platinum-based regimen, had a cancer antigen 125 concentration of less than the upper limit of normal, had a performance status of 0–1, and had adequate organ function. Patients were ineligible if they had symptomatic or untreated central nervous system metastases, had received anticancer therapy 14 days or fewer before starting the study, or had received previous treatment with a poly(ADP-ribose) polymerase inhibitor. We randomly allocated patients 2:1 to receive oral rucaparib 600 mg twice daily or placebo in 28 day cycles using a computer-generated sequence (block size of six, stratified by homologous recombination repair gene mutation status, progression-free interval after the penultimate platinum-based regimen, and best response to the most recent platinum-based regimen). Patients, investigators, site staff, assessors, and the funder were masked to assignments. The primary outcome was investigator-assessed progression-free survival evaluated with use of an ordered step-down procedure for three nested cohorts: patients with BRCA mutations (carcinoma associated with deleterious germline or somatic BRCA mutations), patients with homologous recombination deficiencies (BRCA mutant or BRCA wild-type and high loss of heterozygosity), and the intention-to-treat population, assessed at screening and every 12 weeks thereafter. This trial is registered with ClinicalTrials.gov, number NCT01968213; enrolment is complete. Findings: Between April 7, 2014, and July 19, 2016, we randomly allocated 564 patients: 375 (66%) to rucaparib and 189 (34%) to placebo. Median progression-free survival in patients with a BRCA-mutant carcinoma was 16·6 months (95% CI 13·4–22·9; 130 [35%] patients) in the rucaparib group versus 5·4 months (3·4–6·7; 66 [35%] patients) in the placebo group (hazard ratio 0·23 [95% CI 0·16–0·34]; p<0·0001). In patients with a homologous recombination deficient carcinoma (236 [63%] vs 118 [62%]), it was 13·6 months (10·9–16·2) versus 5·4 months (5·1–5·6; 0·32 [0·24–0·42]; p<0·0001). In the intention-to-treat population, it was 10·8 months (8·3–11·4) versus 5·4 months (5·3–5·5; 0·36 [0·30–0·45]; p<0·0001). Treatment-emergent adverse events of grade 3 or higher in the safety population (372 [99%] patients in the rucaparib group vs 189 [100%] in the placebo group) were reported in 209 (56%) patients in the rucaparib group versus 28 (15%) in the placebo group, the most common of which were anaemia or decreased haemoglobin concentration (70 [19%] vs one [1%]) and increased alanine or aspartate aminotransferase concentration (39 [10%] vs none). Interpretation: Across all primary analysis groups, rucaparib significantly improved progression-free survival in patients with platinum-sensitive ovarian cancer who had achieved a response to platinum-based chemotherapy. ARIEL3 provides further evidence that use of a poly(ADP-ribose) polymerase inhibitor in the maintenance treatment setting versus placebo could be considered a new standard of care for women with platinum-sensitive ovarian cancer following a complete or partial response to second-line or later platinum-based chemotherapy. Funding: Clovis Oncology

Evidence for the generation of juvenile granitic crust during continental extension, Mineral Mountains Batholith, Utah

This is the published version. Copyright 1976 American Geophysical Union. All Rights Reserved.Field, chemical and isotopic data from the Miocene Mineral Mountains batholith in southwest Utah are consistent with the batholith being derived through differentiation of material recently separated from the lithospheric mantle, with little involvement of pre-Oligocene crust. The batholith ranges in composition and texture from diabase and gabbro to high-silica rhyolite and granite and is distinctly calcalkaline in nature. Field evidence for anatexis of intermediate-composition Oligocene crust and magma mixing suggest that fractional melting and mixing were important processes during the evolution of the batholith. Major oxide and rare earth element data for the batholith are consistent with chemical evolution of the magma system being controlled by fractionation of hornblende, plagioclase and sphene (all of which occur in restitic portions of Miocene migmatites exposed in the field area) during partial melting, and mixing between gabbro and granite. Isotopic data indicate a lithospheric mantle source for mafic rocks in the study area and, on the basis of field data and their similarity in isotopic composition, granitic rocks are interpreted to be derived indirectly from the same source during Basin and Range extension. Evolution of the granites is hypothesized to involve a series of partial melting steps, one of which is exposed in the batholith, which refine mantle-derived gabbros into high-silica rocks. Thus the Mineral Mountains batholith represents juvenile granitic material added to the crust during extension. This raises the possibility that extension may be an important granitic crust-forming event. Furthermore, this suggests that pure-shear igneous inflation of the crust by the mantle can be an important mechanism during extensional deformation. Data presented here indicate that fractional melting of young mafic crust may be an important process in the evolution of isotopically homogeneous intrusive suites which span a broad compositional range. Furthermore, the data support the idea that lithospheric mantle in the Great Basin region may be Proterozoic in age

STREGA: STRucture and Evolution of the GAlaxy - I : Survey overview and first results

STREGA (STRucture and Evolution of the GAlaxy) is a guaranteed time survey being performed at the VST (the ESO Very Large Telescope Survey Telescope) to map about 150 square degrees in the Galactic halo, in order to constrain the mechanisms of galactic formation and evolution. The survey is built as a 5 yr project, organized in two parts: a core programme to explore the surrounding regions of selected stellar systems and a second complementary part to map the southern portion of the Fornax orbit and extend the observations of the core programme. The adopted stellar tracers are mainly variable stars (RR Lyraes and long-period variables) and main-sequence turn-off stars for which observations in the g, r, i bands are obtained. We present an overview of the survey and some preliminary results for three observing runs that have been completed. For the region centred on ω Cen (37 deg^2), covering about three tidal radii, we also discuss the detected stellar density radial profile and angular distribution, leading to the identification of extratidal cluster stars. We also conclude that the cluster tidal radius is about 1.2 deg, in agreement with values in the literature based on the Wilson model.Peer reviewedFinal Accepted Versio

PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy

PPM1D encodes a phosphatase that is recurrently activated across cancer, most notably in therapy-related myeloid neoplasms. However, the function of PPM1D in hematopoiesis and its contribution to tumor cell growth remain incompletely understood. Using conditional mouse models, we uncover a central role for Ppm1d in hematopoiesis and validate its potential as a therapeutic target. We find that Ppm1d regulates the competitive fitness and self-renewal of hematopoietic stem cells (HSCs) with and without exogenous genotoxic stresses. We also show that while Ppm1d activation confers cellular resistance to cytotoxic therapy, it does so to a lesser degree than p53 loss, informing the clonal competition phenotypes often observed in human studies. Notably, loss of Ppm1d sensitizes leukemias to cytotoxic therapies in vitro and in vivo, even in the absence of a Ppm1d mutation. Vulnerability to PPM1D inhibition is observed across many cancer types and dependent on p53 activity. Importantly, organism-wide loss of Ppm1d in adult mice is well tolerated, supporting the tolerability of pharmacologically targeting PPM1D. Our data link PPM1D gain-of-function mutations to the clonal expansion of HSCs, inform human genetic observations, and support the therapeutic targeting of PPM1D in cancer

Impact Factor: outdated artefact or stepping-stone to journal certification?

A review of Garfield's journal impact factor and its specific implementation as the Thomson Reuters Impact Factor reveals several weaknesses in this commonly-used indicator of journal standing. Key limitations include the mismatch between citing and cited documents, the deceptive display of three decimals that belies the real precision, and the absence of confidence intervals. These are minor issues that are easily amended and should be corrected, but more substantive improvements are needed. There are indications that the scientific community seeks and needs better certification of journal procedures to improve the quality of published science. Comprehensive certification of editorial and review procedures could help ensure adequate procedures to detect duplicate and fraudulent submissions.Comment: 25 pages, 12 figures, 6 table